Biora Therapeutics Inc.

0.6988-0.0012-0.17%Vol 736.80K1Y Perf -79.47%
Jul 1st, 2022 16:00 DELAYED
BID0.6989 ASK0.7100
Open0.6900 Previous Close0.7000
Pre-Market- After-Market0.69
 - -  -0.01 -1.04%
Target Price
4.00 
Analyst Rating
Moderate Buy 1.67
Potential %
472.41 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Price Range Ratio 52W %
2.46 
Earnings Rating
Market Cap128.72M 
Earnings Date
11th Aug 2022
Alpha-0.04 Standard Deviation0.42
Beta1.03 

Today's Price Range

0.69000.7300

52W Range

0.56006.20

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Sell
Performance
1 Week
1.72%
1 Month
-13.01%
3 Months
-38.70%
6 Months
-66.56%
1 Year
-79.47%
3 Years
-
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
BIOR0.6988-0.0012-0.17
AAPL138.932.21001.62
GOOG2 181.62-5.8300-0.27
MSFT259.582.75001.07
XOM87.551.91002.23
WFC39.920.75001.91
JNJ179.522.01001.13
FB196.640.99000.51
GE63.54-0.1300-0.20
JPM114.051.44001.28
Earnings HistoryEstimateReportedSurprise %
Q01 2022-0.12-0.120.00
Q04 2021-0.13-0.21-61.54
Q03 2021-0.47-0.3819.15
Q02 2021-0.80-0.6518.75
Q01 2021-0.83-0.5632.53
Q04 2020-0.76-1.53-101.32
Q03 2020-0.62-1.01-62.90
Q02 2020-0.76-6.11-703.95
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date11th Aug 2022
Estimated EPS Next Report-0.13
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume736.80K
Shares Outstanding184.20K
Shares Float166.46M
Trades Count2.65K
Dollar Volume520.57K
Avg. Volume2.76M
Avg. Weekly Volume3.20M
Avg. Monthly Volume1.90M
Avg. Quarterly Volume3.19M

Biora Therapeutics Inc. (NASDAQ: BIOR) stock closed at 0.6988 per share at the end of the most recent trading day (a -0.17% change compared to the prior day closing price) with a volume of 736.80K shares and market capitalization of 128.72M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 124 people. Biora Therapeutics Inc. CEO is Aditya P. Mohanty.

The one-year performance of Biora Therapeutics Inc. stock is -79.47%, while year-to-date (YTD) performance is -66.56%. BIOR stock has a five-year performance of %. Its 52-week range is between 0.56 and 6.2, which gives BIOR stock a 52-week price range ratio of 2.46%

Biora Therapeutics Inc. currently has a PE ratio of -0.30, a price-to-book (PB) ratio of -, a price-to-sale (PS) ratio of 109.32, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -219.99%, a ROC of -% and a ROE of 216.30%. The company’s profit margin is -%, its EBITDA margin is -8 843.00%, and its revenue ttm is $1.19 Million , which makes it $0.01 revenue per share.

Of the last four earnings reports from Biora Therapeutics Inc., there were 2 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $-0.13 for the next earnings report. Biora Therapeutics Inc.’s next earnings report date is 11th Aug 2022.

The consensus rating of Wall Street analysts for Biora Therapeutics Inc. is Moderate Buy (1.67), with a target price of $4, which is +472.41% compared to the current price. The earnings rating for Biora Therapeutics Inc. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Biora Therapeutics Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Biora Therapeutics Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 34.20, ATR14 : 0.07, CCI20 : 28.57, Chaikin Money Flow : -0.08, MACD : -0.03, Money Flow Index : 62.83, ROC : 23.70, RSI : 48.68, STOCH (14,3) : 61.99, STOCH RSI : 0.68, UO : 47.70, Williams %R : -38.01), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Biora Therapeutics Inc. in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (66.67 %)
2 (50.00 %)
1 (33.33 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
1 (33.33 %)
2 (50.00 %)
2 (66.67 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingModerate Buy
1.67
Moderate Buy
2.00
Moderate Buy
2.33

Biora Therapeutics Inc.

Biora Therapeutics Inc, formerly Progenity Inc is a biotechnology company engaged in developing oral biotherapeutics. Its drug-device combinations could enable new treatment approaches in the delivery of therapeutics in two main areas: Targeted delivery of therapeutics to the site of disease in the gastrointestinal ("GI") tract, which is designed to improve outcomes for patients with Inflammatory Bowel Disease (IBD); and Systemic delivery of biotherapeutics, which are designed to replace injection with needle-free, oral delivery technology. Geographically, it operates only in the United States. It generates revenue from providing molecular laboratory tests to customers.

CEO: Aditya P. Mohanty

Telephone: +1 855 293-2639

Address: 4330 La Jolla Village Drive, San Diego 92122, CA, US

Number of employees: 124

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

50%50%

Bearish Bullish

50%50%

Bearish Bullish

50%50%

News

Stocktwits